Latest Healthtech Startup Funding Rounds
Companies building technology for healthcare delivery, diagnosis, clinical workflows and patient access.
- Rounds
- 740 Jan 1 – Oct 24, 2026
- Disclosed funding
- $25.3B 605 disclosed amounts
- Median round
- $16M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| SP Spotlight PathologyCompany profile Develops AI software for digital pathology image analysis to support clinicians Develops AI software for digital pathology image analysis to support clinicians | £1.4M | Seed | Healthtech | United Kingdom | Investors | |
| MH Provides evidence-based obesity care platform | Undisclosed | StrategicUndisclosed | Healthtech | United States | Investors | |
| B Develops culturally intelligent AI for therapy and mental health services | $270K | Seed | Healthtech | Finland | Investors | |
| N NitraCompany profile AI-native operating system for healthcare practices to automate back office functions AI-native operating system for healthcare practices to automate back office functions | $187M | Series A+Series B+DebtUndisclosed | Healthtech | United States | Investors | |
| AA Amigo AICompany profile Concurrence, formerly Amigo AI, builds clinical AI agents and shared patient-data infrastructure for healthcare organizations. Concurrence, formerly Amigo AI, builds clinical AI agents and shared patient-data infrastructure for healthcare organizations. | $11M | Series A | Healthtech | United States | Investors | |
| MH May HealthCompany profile Provides medical device solutions for women living with polycystic ovary syndrome (PCOS) Provides medical device solutions for women living with polycystic ovary syndrome (PCOS) | $11.7M | Seed | Healthtech | United States | Investors | |
| M MindImmuneCompany profile Develops immune-focused therapies for neurodegenerative diseases, including Alzheimer’s disease Develops immune-focused therapies for neurodegenerative diseases, including Alzheimer’s disease | $5M | StrategicUndisclosed | Healthtech, Biotech | United States | Investors | |
| NM Develops neuromodulation technologies for chronic post-amputation pain | $35M | Growth | Healthtech | United States | Investors | |
| V VitestroCompany profile Develops autonomous robotic phlebotomy devices for diagnostic blood collection Develops autonomous robotic phlebotomy devices for diagnostic blood collection | $70M | Series B | Healthtech | Netherlands | Investors | |
| SC Science CorporationCompany profile Develops brain-computer interface retinal implants to restore vision in patients with retinal diseases Develops brain-computer interface retinal implants to restore vision in patients with retinal diseases | $230M | Series CSeries C+ | Healthtech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · From Jan 1, 2026
- 1General Catalyst
Baba, Disha (formerly Curelink), Thatch
23rounds2led - 2Y Combinator (YC)
Vitalize, Angle Health, Metriport
21rounds0led - 3Alumni Ventures
MintNeuro, Evvy, Hopscotch Primary Care
13rounds0led - 4Andreessen Horowitz (a16z)
Sharp Performance, General Medicine, Devoted Health
12rounds2led - 5Khosla Ventures
Even Healthcare, Abby Care, Rightway
11rounds1led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.